First Time Loading...

Imara Inc
NASDAQ:IMRA

Watchlist Manager
Imara Inc Logo
Imara Inc
NASDAQ:IMRA
Watchlist
Price: 21 USD 232.28% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

IMRA's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Imara, Inc. is a clinical-stage biopharmaceutical company. [ Read More ]

The intrinsic value of one IMRA stock under the Base Case scenario is 2.87 USD. Compared to the current market price of 21 USD, Imara Inc is Overvalued by 86%.

Key Points:
IMRA Intrinsic Value
Base Case
2.87 USD
Overvaluation 86%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Imara Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IMRA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Imara Inc

Provide an overview of the primary business activities
of Imara Inc.

What unique competitive advantages
does Imara Inc hold over its rivals?

What risks and challenges
does Imara Inc face in the near future?

Has there been any significant insider trading activity
in Imara Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Imara Inc.

Provide P/S
for Imara Inc.

Provide P/E
for Imara Inc.

Provide P/OCF
for Imara Inc.

Provide P/FCFE
for Imara Inc.

Provide P/B
for Imara Inc.

Provide EV/S
for Imara Inc.

Provide EV/GP
for Imara Inc.

Provide EV/EBITDA
for Imara Inc.

Provide EV/EBIT
for Imara Inc.

Provide EV/OCF
for Imara Inc.

Provide EV/FCFF
for Imara Inc.

Provide EV/IC
for Imara Inc.

Show me price targets
for Imara Inc made by professional analysts.

What are the Revenue projections
for Imara Inc?

How accurate were the past Revenue estimates
for Imara Inc?

What are the Net Income projections
for Imara Inc?

How accurate were the past Net Income estimates
for Imara Inc?

What are the EPS projections
for Imara Inc?

How accurate were the past EPS estimates
for Imara Inc?

What are the EBIT projections
for Imara Inc?

How accurate were the past EBIT estimates
for Imara Inc?

Compare the revenue forecasts
for Imara Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Imara Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Imara Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Imara Inc compared to its peers.

Compare the P/E ratios
of Imara Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Imara Inc with its peers.

Analyze the financial leverage
of Imara Inc compared to its main competitors.

Show all profitability ratios
for Imara Inc.

Provide ROE
for Imara Inc.

Provide ROA
for Imara Inc.

Provide ROIC
for Imara Inc.

Provide ROCE
for Imara Inc.

Provide Gross Margin
for Imara Inc.

Provide Operating Margin
for Imara Inc.

Provide Net Margin
for Imara Inc.

Provide FCF Margin
for Imara Inc.

Show all solvency ratios
for Imara Inc.

Provide D/E Ratio
for Imara Inc.

Provide D/A Ratio
for Imara Inc.

Provide Interest Coverage Ratio
for Imara Inc.

Provide Altman Z-Score Ratio
for Imara Inc.

Provide Quick Ratio
for Imara Inc.

Provide Current Ratio
for Imara Inc.

Provide Cash Ratio
for Imara Inc.

What is the historical Revenue growth
over the last 5 years for Imara Inc?

What is the historical Net Income growth
over the last 5 years for Imara Inc?

What is the current Free Cash Flow
of Imara Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Imara Inc.

Financials

Balance Sheet Decomposition
Imara Inc

Current Assets 77.8m
Cash & Short-Term Investments 75.5m
Other Current Assets 2.2m
Non-Current Assets 5.5m
PP&E 1.5m
Other Non-Current Assets 4m
Current Liabilities 9.7m
Accounts Payable 3.4m
Accrued Liabilities 6.3m
Non-Current Liabilities 659k
Other Non-Current Liabilities 659k
Efficiency

Earnings Waterfall
Imara Inc

Revenue
0 USD
Operating Expenses
-34.3m USD
Operating Income
-34.3m USD
Other Expenses
35.8m USD
Net Income
1.5m USD

Free Cash Flow Analysis
Imara Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

IMRA Profitability Score
Profitability Due Diligence

Imara Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score

Imara Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

IMRA Solvency Score
Solvency Due Diligence

Imara Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Imara Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMRA Price Targets Summary
Imara Inc

There are no price targets for IMRA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

IMRA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

IMRA Price
Imara Inc

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-33%
5Y 5Y
-65%
10Y 10Y
-65%
Annual Price Range
21
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return -15.04%
Standard Deviation of Annual Returns 105.94%
Max Drawdown -98%
Shares Statistics
Market Capitalization 552m USD
Shares Outstanding 26 287 300
Percentage of Shares Shorted 2.46%

IMRA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Imara Inc Logo
Imara Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

552m USD

Dividend Yield

0%

Description

Imara, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Boston, Massachusetts and currently employs 41 full-time employees. The company went IPO on 2020-03-12. The firm is engaged in developing and commercializing novel therapeutics to treat rare inherited genetic disorders of hemoglobin. The Company’s product pipeline includes IMR-687 (tovinontrine). IMR-687 is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease (SCD and beta-thalassemi. IMR-687 is a selective, potent small molecule inhibitor of phosphodiesterase-9 (PDE9), that has a multimodal mechanism of action that acts primarily on red blood cells (RBCs) and has the potential to act on white blood cells (WBCs), adhesion mediators and other cell types. PDE9 decreases cyclic guanosine monophosphate (cGMP), an active signaling molecule. The firm is conducting Phase II b clinical trials of IMR-68.

Contact

MASSACHUSETTS
Boston
116 Huntington Avenue, 6Th Floor
+16172062020.0
https://imaratx.com/

IPO

2020-03-12

Employees

41

Officers

Pres, CEO & Director
Dr. Rahul D. Ballal Ph.D.
CFO & COO
Mr. Michael P. Gray MBA, CPA
Sr. VP of Legal & Gen. Counsel
Mr. Stephen M. Migausky J.D.

See Also

Discover More
What is the Intrinsic Value of one IMRA stock?

The intrinsic value of one IMRA stock under the Base Case scenario is 2.87 USD.

Is IMRA stock undervalued or overvalued?

Compared to the current market price of 21 USD, Imara Inc is Overvalued by 86%.